FundLens
33
Pharma & HealthcareAvoid

Baroda BNP Paribas Health And Wellness

Baroda BNP Paribas · Direct–Growth · rank #15 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
16.0%
+15.2% vs index
3 Years
—
5 Years
—
Since launch
8.7%

Year-by-year performance

last entry = YTD
2026
+17.7%

Why this score

Baroda BNP Paribas Health And Wellness scores 33/100 — #15 of 19 Pharma & Healthcare fund (Avoid). It stands out for volatility — beating 97% of peers on volatility. The main drag is its sharpe ratio (better than only 3% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

Sharpe ratio0.18 · 3rd percentile in category
Volatility11.98 · 97th percentile in category
Expense ratio1.47% · 8th percentile in category
Sortino ratio0.26 · 3rd percentile in category
1Y return15.99% · 21st percentile in category
Fund size477.74 Cr · 39th percentile in category

Top holdings

top 5 = 38.4% of portfolio
1.Sun Pharmaceutical Industries Ltd8.58%
2.Divi's Laboratories Ltd8.41%
3.Torrent Pharmaceuticals Ltd7.74%
4.Laurus Labs Ltd7.56%
5.Ipca Laboratories Ltd6.06%

33 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds